DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Brain Function and EEG

Early Phase 1

Completed

Conditions: Healthy
Mood

Interventions: Drug: Methamphetamine
Drug: Placebo

First Posted Date: 2021-08-12

Last Posted Date: 2024-01-24

Lead Sponsor: University of Chicago

Target Recruit Count: 40

Registration Number: NCT05003076

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Epidiolex in Obsessive Compulsive Disorder and Related Disorders

Phase 2

Active, not recruiting

Conditions: Tourette Syndrome
Obsessive-Compulsive Disorder
Trichotillomania (Hair-Pulling Disorder)
Hoarding Disorder

Interventions: Drug: Cannabidiol

First Posted Date: 2021-07-27

Last Posted Date: 2025-05-04

Lead Sponsor: University of Chicago

Target Recruit Count: 4

Registration Number: NCT04978428

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

My Diabetes, My Community

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Behavioral: My Diabetes Goal
Behavioral: My Diabetes Goal + CommunityRx

First Posted Date: 2021-07-21

Last Posted Date: 2024-11-06

Lead Sponsor: University of Chicago

Target Recruit Count: 505

Registration Number: NCT04970810

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States

Family Supports and Beliefs Survey

Not Applicable

Completed

Conditions: Beliefs About Child Development

Interventions: Behavioral: High SES/Low Supports
Behavioral: Low SES/ Low Supports
Behavioral: High SES/High Supports
Behavioral: Low SES/High Supports

First Posted Date: 2021-07-21

Last Posted Date: 2022-09-22

Lead Sponsor: University of Chicago

Target Recruit Count: 205

Registration Number: NCT04971265

Locations: 🇺🇸
TMW Center for Early Learning + Public Health at the University of Chicago Medicine, Chicago, Illinois, United States

A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms

Phase 1

Withdrawn

Conditions: IDH Mutation
IDH1 Mutation
IDH2 Gene Mutation
Blood Cancer
Myeloproliferative Neoplasm

Interventions: Drug: Ivosidenib
Drug: Enasidenib
Drug: Fedratinib

First Posted Date: 2021-07-09

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Registration Number: NCT04955938

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients

Not Applicable

Completed

Conditions: Hypoxia
SARS-CoV-2 Acute Respiratory Disease
Carotid Bodies

First Posted Date: 2021-07-08

Last Posted Date: 2022-11-16

Lead Sponsor: University of Chicago

Target Recruit Count: 80

Registration Number: NCT04954157

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

Phase 2

Recruiting

Conditions: Long COVID
Pulmonary Fibrosis
COVID-19 Pneumonia

Interventions: Drug: Sirolimus

First Posted Date: 2021-07-01

Last Posted Date: 2024-08-01

Lead Sponsor: University of Chicago

Target Recruit Count: 60

Registration Number: NCT04948203

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Turning Dexmedetomidine Into a Powerful Anesthetic That Can be Rapidly and Completely Reversed

Phase 1

Withdrawn

Conditions: Emergence From Anesthesia

Interventions: Drug: Dexmedetomidine Hydrochloride & Saline
Drug: Atipamezole & Caffeine

First Posted Date: 2021-06-28

Last Posted Date: 2023-05-17

Lead Sponsor: University of Chicago

Registration Number: NCT04942340

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels

Phase 2

Withdrawn

Conditions: Gastric Adenocarcinoma
Lung Cancer
Metastatic Cancer
Foregut Carcinoid Tumor
Gallbladder Adenocarcinoma
GI Cancer
GI Carcinoma
Liver Cancer

Interventions: Procedure: Video-Assisted Thoracic Surgery (VATS)
Drug: Standard of Care Chemotherapy
Procedure: Lobectomy
Radiation: Consolidative Radiation
Radiation: Ablation Treatment
Procedure: Resection or Excision
Procedure: Peritonectomy
Other: Transarterial Radioembolization

First Posted Date: 2021-06-18

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Registration Number: NCT04931420

Reducing Opioid Mortality in Illinois

Not Applicable

Recruiting

Conditions: Opioid Use
Opioid-use Disorder

Interventions: Behavioral: Naloxone-Only
Behavioral: Case Management and Peer Recovery

First Posted Date: 2021-06-14

Last Posted Date: 2024-02-21

Lead Sponsor: University of Chicago

Target Recruit Count: 1500

Registration Number: NCT04925427

Locations: 🇺🇸
Jackson County Jail, Murphysboro, Illinois, United States
🇺🇸
LaSalle County Jail, Ottawa, Illinois, United States
🇺🇸
Cook County Department of Corrections, Chicago, Illinois, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy